RecallRadar

FDA Drug recall D-0545-2025

Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New…

On 2025-08-06 the FDA classified a Class II recall of Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New… by Pfizer, citing CGMP Deviations; particulates identified during visual inspection.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0545-2025
ClassificationClass II
Statusongoing
Initiated2025-07-10
Published2025-08-06
Last updated2026-09-13 11:52 UTC
CompanyPfizer
DistributionUS

Product

Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04

Reason

CGMP Deviations; particulates identified during visual inspection

Identifiers

ndc60793-700-01
ndc60793-700-10
ndc60793-701-02
ndc60793-701-10
ndc60793-702-04
ndc60793-702-10
code_infoLots GT2598, GT2599, Exp 09/30/26; HK2909, Exp 02/28/27; HR9969, Exp 04/30/27; HR9984, Exp 08/31/27.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0545-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.